Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Huge Potential

By HEFFX Australia on June 29, 2020   Headline News, Health, Heffx Insights, Investments, Shayne Heffernan, Shayne Heffernan, Stocks, Todays Trade Ideas, Top Stories, US Stocks  

$CTXR #NASDAQ #Stocks #Shayne Heffernan #StrongBuy #MedicalResearch Rallies on accelerated review prospects for stem cells for COVID-19 Citius PharmaceuticalsTicker: NASDAQ:CTXRPrice: $1.38Recommendation: Strong BuyTarget Price: $5.50 Company News Citius Pharmaceuticals, Inc. (CTXR) said it has received a written response from the FDA with respect to the company’s pre-investigational new drug application for induced mesenchymal stem cells […]